Evidence map›Paper›PMID 38162498›Full record

ArticleFrontiers in oncology2023

Targeted therapy for multiple gene mutations in multiple metastases of advanced gastric cancer: a case report.

Xin Zhang, Xinran Zhang, Dandan Geng, Chenguang Zhao, Yingnan Wang, Yao Fan, Shasha Gao, Jinmei Wei, Fengbin Zhang

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xin Zhang *Department of Gastroenterology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Xinran Zhang *Department of Gastroenterology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Dandan GengDepartment of Neurology, The People's Hospital of Hebei Province, Shijiazhuang, Hebei, China.
Chenguang ZhaoDepartment of Internal Medicine, Baoding Orthopedic Hospital/People's Hospital of Lianchi District, Baoding, Hebei, China.
Yingnan WangDepartment of Gastroenterology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Yao FanDepartment of Gastroenterology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Shasha GaoDepartment of Gastroenterology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Jinmei WeiDepartment of Gastroenterology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Fengbin ZhangDepartment of Gastroenterology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Hebei Medical University · CNBaoding People's Hospital · CNHospital of Hebei Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In China, gastric cancer is the second most common cause of cancer-related death, after lung cancer. At present, the morbidity and mortality rates of gastric cancer are increasing, and targeted therapy for gastric cancer has become a research hotspot. Herein, we report a patient with multiple metastases from advanced gastric cancer. After identifying

Indexed as

gastric adenocarcinomaHER-2 amplificationheterogeneityMET amplificationtargeted therapy

Identifiers

PMID38162498
PMCPMC10755568
OpenAlexW4389785671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.